Marfan syndrome is a genetic disease that affects the connective tissue in the body that provides strength, support, and elasticity to tendons. This effects eyes, bones, skin, lungs, nervous system, and the heart and blood vessels. Marfan syndrome can be deadly if the disease causes damage to the aorta, causing bleeding in the inner walls of the vessel. If this happens surgery to replace the affected part of the aorta is often required. Marfan syndrome is relatively common, 1 in every 5,000 people have this syndrome. There is no cure for Marfan syndrome, however the life expectancy of a person with Marfan syndrome is that of an average person. Clinical trials are promising treatments to cure Marfan syndrome but for now issues are addressed as they arise.
Marfan Syndrome Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Marfan Syndrome below!
For more information on how to use Laverne, please read the How to Guide.
We have 1459 products for the study of Marfan Syndrome that can be applied to Chromatin Immunoprecipitation, Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.
Marfan Syndrome is also known as marfan syndrome, arachnodactyly, marfan's syndrome (disorder), mfs, contractural arachnodactyly, marfan syndrome type 1, marfan's syndrome.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.